Global Ophthalmic Combination Product Market Growth (Status and Outlook) 2024-2030

Publication ID:

LPI11247150

Publication Date:

November 14, 2024

Pages:

122

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

An ophthalmic combination product refers to a medical device that integrates with a drug or biologic component for use in treating conditions related to the eye. These products are designed to deliver medications directly to the eye through various delivery mechanisms such as eye drops, ointments, or intraocular devices. They are used to manage a wide range of ophthalmic conditions including glaucoma, dry eye syndrome, and ocular infections. The integration of drug and device components in these products ensures precise dosing, targeted delivery, and efficacy in treating eye disorders while enhancing patient convenience and compliance.
The global Ophthalmic Combination Product market size is projected to grow from US$ 13180 million in 2024 to US$ 20190 million in 2030; it is expected to grow at a CAGR of 7.4% from 2024 to 2030.
LPI (publisher)' newest research report, the 鈥淥phthalmic Combination Product Industry Forecast鈥� looks at past sales and reviews total world Ophthalmic Combination Product sales in 2022, providing a comprehensive analysis by region and market sector of projected Ophthalmic Combination Product sales for 2023 through 2029. With Ophthalmic Combination Product sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Ophthalmic Combination Product industry.
This Insight Report provides a comprehensive analysis of the global Ophthalmic Combination Product landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Ophthalmic Combination Product portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Ophthalmic Combination Product market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Ophthalmic Combination Product and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Ophthalmic Combination Product.
United States market for Ophthalmic Combination Product is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Ophthalmic Combination Product is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Ophthalmic Combination Product is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Ophthalmic Combination Product players cover Alcon, Alimera Sciences, AbbVie, Bausch + Lomb, Bayer, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Ophthalmic Combination Product market by product type, application, key players and key regions and countries.
Segmentation by Type:
Devices
Drugs
Segmentation by Application:
Glaucoma
Post-surgery Inflammation
Dry Eye Syndrome
Allergic Conjunctivitis
Diabetic Retinopathy
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Segmentation by Type:
Devices
Drugs
Segmentation by Application:
Glaucoma
Post-surgery Inflammation
Dry Eye Syndrome
Allergic Conjunctivitis
Diabetic Retinopathy
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Alcon
Alimera Sciences
AbbVie
Bausch + Lomb
Bayer
DoseLogix
Eyedaptic
Eyenovia
MicroMedical Devices
Mylan (Viatris)
Novartis
Ocular Therapeutix
Pfizer
pSivida Corp.
Roche
Santen Pharmaceutical
Teva Pharmaceutical

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Ophthalmic Combination Product Market Size 2019-2030
2.1.2 Ophthalmic Combination Product Market Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for Ophthalmic Combination Product by Country/Region, 2019, 2023 & 2030
2.2 Ophthalmic Combination Product Segment by Type
2.2.1 Devices
2.2.2 Drugs
2.3 Ophthalmic Combination Product Market Size by Type
2.3.1 Ophthalmic Combination Product Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Ophthalmic Combination Product Market Size Market Share by Type (2019-2024)
2.4 Ophthalmic Combination Product Segment by Application
2.4.1 Glaucoma
2.4.2 Post-surgery Inflammation
2.4.3 Dry Eye Syndrome
2.4.4 Allergic Conjunctivitis
2.4.5 Diabetic Retinopathy
2.4.6 Other
2.5 Ophthalmic Combination Product Market Size by Application
2.5.1 Ophthalmic Combination Product Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Ophthalmic Combination Product Market Size Market Share by Application (2019-2024)
3 Ophthalmic Combination Product Market Size by Player
3.1 Ophthalmic Combination Product Market Size Market Share by Player
3.1.1 Global Ophthalmic Combination Product Revenue by Player (2019-2024)
3.1.2 Global Ophthalmic Combination Product Revenue Market Share by Player (2019-2024)
3.2 Global Ophthalmic Combination Product Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Ophthalmic Combination Product by Region
4.1 Ophthalmic Combination Product Market Size by Region (2019-2024)
4.2 Global Ophthalmic Combination Product Annual Revenue by Country/Region (2019-2024)
4.3 Americas Ophthalmic Combination Product Market Size Growth (2019-2024)
4.4 APAC Ophthalmic Combination Product Market Size Growth (2019-2024)
4.5 Europe Ophthalmic Combination Product Market Size Growth (2019-2024)
4.6 Middle East & Africa Ophthalmic Combination Product Market Size Growth (2019-2024)
5 Americas
5.1 Americas Ophthalmic Combination Product Market Size by Country (2019-2024)
5.2 Americas Ophthalmic Combination Product Market Size by Type (2019-2024)
5.3 Americas Ophthalmic Combination Product Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Ophthalmic Combination Product Market Size by Region (2019-2024)
6.2 APAC Ophthalmic Combination Product Market Size by Type (2019-2024)
6.3 APAC Ophthalmic Combination Product Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Ophthalmic Combination Product Market Size by Country (2019-2024)
7.2 Europe Ophthalmic Combination Product Market Size by Type (2019-2024)
7.3 Europe Ophthalmic Combination Product Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Ophthalmic Combination Product by Region (2019-2024)
8.2 Middle East & Africa Ophthalmic Combination Product Market Size by Type (2019-2024)
8.3 Middle East & Africa Ophthalmic Combination Product Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Ophthalmic Combination Product Market Forecast
10.1 Global Ophthalmic Combination Product Forecast by Region (2025-2030)
10.1.1 Global Ophthalmic Combination Product Forecast by Region (2025-2030)
10.1.2 Americas Ophthalmic Combination Product Forecast
10.1.3 APAC Ophthalmic Combination Product Forecast
10.1.4 Europe Ophthalmic Combination Product Forecast
10.1.5 Middle East & Africa Ophthalmic Combination Product Forecast
10.2 Americas Ophthalmic Combination Product Forecast by Country (2025-2030)
10.2.1 United States Market Ophthalmic Combination Product Forecast
10.2.2 Canada Market Ophthalmic Combination Product Forecast
10.2.3 Mexico Market Ophthalmic Combination Product Forecast
10.2.4 Brazil Market Ophthalmic Combination Product Forecast
10.3 APAC Ophthalmic Combination Product Forecast by Region (2025-2030)
10.3.1 China Ophthalmic Combination Product Market Forecast
10.3.2 Japan Market Ophthalmic Combination Product Forecast
10.3.3 Korea Market Ophthalmic Combination Product Forecast
10.3.4 Southeast Asia Market Ophthalmic Combination Product Forecast
10.3.5 India Market Ophthalmic Combination Product Forecast
10.3.6 Australia Market Ophthalmic Combination Product Forecast
10.4 Europe Ophthalmic Combination Product Forecast by Country (2025-2030)
10.4.1 Germany Market Ophthalmic Combination Product Forecast
10.4.2 France Market Ophthalmic Combination Product Forecast
10.4.3 UK Market Ophthalmic Combination Product Forecast
10.4.4 Italy Market Ophthalmic Combination Product Forecast
10.4.5 Russia Market Ophthalmic Combination Product Forecast
10.5 Middle East & Africa Ophthalmic Combination Product Forecast by Region (2025-2030)
10.5.1 Egypt Market Ophthalmic Combination Product Forecast
10.5.2 South Africa Market Ophthalmic Combination Product Forecast
10.5.3 Israel Market Ophthalmic Combination Product Forecast
10.5.4 Turkey Market Ophthalmic Combination Product Forecast
10.6 Global Ophthalmic Combination Product Forecast by Type (2025-2030)
10.7 Global Ophthalmic Combination Product Forecast by Application (2025-2030)
10.7.1 GCC Countries Market Ophthalmic Combination Product Forecast
11 Key Players Analysis
11.1 Alcon
11.1.1 Alcon Company Information
11.1.2 Alcon Ophthalmic Combination Product Product Offered
11.1.3 Alcon Ophthalmic Combination Product Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Alcon Main Business Overview
11.1.5 Alcon Latest Developments
11.2 Alimera Sciences
11.2.1 Alimera Sciences Company Information
11.2.2 Alimera Sciences Ophthalmic Combination Product Product Offered
11.2.3 Alimera Sciences Ophthalmic Combination Product Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Alimera Sciences Main Business Overview
11.2.5 Alimera Sciences Latest Developments
11.3 AbbVie
11.3.1 AbbVie Company Information
11.3.2 AbbVie Ophthalmic Combination Product Product Offered
11.3.3 AbbVie Ophthalmic Combination Product Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 AbbVie Main Business Overview
11.3.5 AbbVie Latest Developments
11.4 Bausch + Lomb
11.4.1 Bausch + Lomb Company Information
11.4.2 Bausch + Lomb Ophthalmic Combination Product Product Offered
11.4.3 Bausch + Lomb Ophthalmic Combination Product Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Bausch + Lomb Main Business Overview
11.4.5 Bausch + Lomb Latest Developments
11.5 Bayer
11.5.1 Bayer Company Information
11.5.2 Bayer Ophthalmic Combination Product Product Offered
11.5.3 Bayer Ophthalmic Combination Product Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Bayer Main Business Overview
11.5.5 Bayer Latest Developments
11.6 DoseLogix
11.6.1 DoseLogix Company Information
11.6.2 DoseLogix Ophthalmic Combination Product Product Offered
11.6.3 DoseLogix Ophthalmic Combination Product Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 DoseLogix Main Business Overview
11.6.5 DoseLogix Latest Developments
11.7 Eyedaptic
11.7.1 Eyedaptic Company Information
11.7.2 Eyedaptic Ophthalmic Combination Product Product Offered
11.7.3 Eyedaptic Ophthalmic Combination Product Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Eyedaptic Main Business Overview
11.7.5 Eyedaptic Latest Developments
11.8 Eyenovia
11.8.1 Eyenovia Company Information
11.8.2 Eyenovia Ophthalmic Combination Product Product Offered
11.8.3 Eyenovia Ophthalmic Combination Product Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Eyenovia Main Business Overview
11.8.5 Eyenovia Latest Developments
11.9 MicroMedical Devices
11.9.1 MicroMedical Devices Company Information
11.9.2 MicroMedical Devices Ophthalmic Combination Product Product Offered
11.9.3 MicroMedical Devices Ophthalmic Combination Product Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 MicroMedical Devices Main Business Overview
11.9.5 MicroMedical Devices Latest Developments
11.10 Mylan (Viatris)
11.10.1 Mylan (Viatris) Company Information
11.10.2 Mylan (Viatris) Ophthalmic Combination Product Product Offered
11.10.3 Mylan (Viatris) Ophthalmic Combination Product Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Mylan (Viatris) Main Business Overview
11.10.5 Mylan (Viatris) Latest Developments
11.11 Novartis
11.11.1 Novartis Company Information
11.11.2 Novartis Ophthalmic Combination Product Product Offered
11.11.3 Novartis Ophthalmic Combination Product Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Novartis Main Business Overview
11.11.5 Novartis Latest Developments
11.12 Ocular Therapeutix
11.12.1 Ocular Therapeutix Company Information
11.12.2 Ocular Therapeutix Ophthalmic Combination Product Product Offered
11.12.3 Ocular Therapeutix Ophthalmic Combination Product Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Ocular Therapeutix Main Business Overview
11.12.5 Ocular Therapeutix Latest Developments
11.13 Pfizer
11.13.1 Pfizer Company Information
11.13.2 Pfizer Ophthalmic Combination Product Product Offered
11.13.3 Pfizer Ophthalmic Combination Product Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Pfizer Main Business Overview
11.13.5 Pfizer Latest Developments
11.14 pSivida Corp.
11.14.1 pSivida Corp. Company Information
11.14.2 pSivida Corp. Ophthalmic Combination Product Product Offered
11.14.3 pSivida Corp. Ophthalmic Combination Product Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 pSivida Corp. Main Business Overview
11.14.5 pSivida Corp. Latest Developments
11.15 Roche
11.15.1 Roche Company Information
11.15.2 Roche Ophthalmic Combination Product Product Offered
11.15.3 Roche Ophthalmic Combination Product Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Roche Main Business Overview
11.15.5 Roche Latest Developments
11.16 Santen Pharmaceutical
11.16.1 Santen Pharmaceutical Company Information
11.16.2 Santen Pharmaceutical Ophthalmic Combination Product Product Offered
11.16.3 Santen Pharmaceutical Ophthalmic Combination Product Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 Santen Pharmaceutical Main Business Overview
11.16.5 Santen Pharmaceutical Latest Developments
11.17 Teva Pharmaceutical
11.17.1 Teva Pharmaceutical Company Information
11.17.2 Teva Pharmaceutical Ophthalmic Combination Product Product Offered
11.17.3 Teva Pharmaceutical Ophthalmic Combination Product Revenue, Gross Margin and Market Share (2019-2024)
11.17.4 Teva Pharmaceutical Main Business Overview
11.17.5 Teva Pharmaceutical Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂